[Treatment of hyperlipidemia in diabetes mellitus].
Onuma
T
T
Department of Internal Medicine, Metabolism and Endocrinology, School of Medicine, Juntendo University.
Kawamori
R
R
D001053:Apolipoproteins / Q000097:blood; D001161:Arteriosclerosis / Q000209:etiology; D002784:Cholesterol; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006801:Humans; D006949:Hyperlipidemias / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D007333:Insulin Resistance; D017270:Lipoprotein(a) / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008075:Lipoproteins, HDL / Q000172:deficiency; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D019518:Postprandial Period; D014280:Triglycerides / Q000097:blood
D001053:Apolipoproteins; D017270:Lipoprotein(a); D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides; C112017:remnant-like particle cholesterol; D002784:Cholesterol